Related Experiment Video
Updated: Jul 25, 2025
Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology
Published on: March 22, 2012
COVID-19-Associated Pulmonary Aspergillosis in Intensive Care Unit Patients from Poland
Magdalena Skóra1, Mateusz Gajda1, Magdalena Namysł2
1Chair of Microbiology, Faculty of Medicine, Jagiellonian University Medical College, Czysta 18 Street, 31-121 Krakow, Poland.
Insights
This study found a high fatality rate of 76.5% for COVID-19-associated pulmonary aspergillosis (CAPA) in Polish intensive care units (ICUs). Increased medical awareness and improved diagnostics are crucial for managing this severe fungal co-infection.
Area of Science:
- Infectious Diseases
- Mycology
- Critical Care Medicine
Background:
- COVID-19 is a known risk factor for invasive fungal infections, particularly aspergillosis.
- Severe COVID-19 cases requiring intensive care unit (ICU) admission are at higher risk.
- Aspergillosis complicates COVID-19, increasing morbidity and mortality.
Purpose of the Study:
- To determine the incidence and characteristics of COVID-19-associated pulmonary aspergillosis (CAPA) in Polish ICU patients.
- To analyze diagnostic and therapeutic approaches for CAPA in this population.
- To highlight the clinical impact and outcomes of CAPA in critically ill COVID-19 patients.
Main Methods:
- Retrospective analysis of medical records from a dedicated COVID-19 ICU in Krakow, Poland (May 2021 - January 2022).
- Inclusion criteria: patients hospitalized in the ICU during the study period.
- Data collected: incidence rates, isolated fungal species, diagnostic procedures, antifungal treatments, and outcomes.
Main Results:
- 17 cases of CAPA were identified, with an incidence density of 9 per 10,000 patient-days and an overall incidence of 1%.
- Aspergillus fumigatus and Aspergillus niger were the most common isolates.
- Antifungal therapy was given to 52.9% of patients, primarily voriconazole (77.8%). The case fatality rate was high at 76.5%.
Conclusions:
- COVID-19-associated pulmonary aspergillosis presents a significant threat in ICUs, with a very high fatality rate.
- There is an urgent need to enhance medical staff awareness regarding fungal co-infections in critically ill COVID-19 patients.
- More effective utilization of diagnostic and therapeutic tools is essential for improving CAPA patient outcomes.
Abstract:
Coronavirus disease 2019 (COVID-19) has been shown to be a favoring factor for aspergillosis, especially in a severe course requiring admission to the intensive care unit (ICU). The aim of the study was to assess the morbidity of CAPA among ICU patients in Poland and to analyze applied diagnostic and therapeutic procedures. Medical documentation of patients hospitalized at the temporary COVID-19 dedicated ICU of the University Hospital in Krakow, Poland, from May 2021 to January 2022 was analyzed. In the analyzed period, 17 cases of CAPA were reported with an incidence density rate of 9 per 10 000 patient days and an incidence rate of 1%. Aspergillus fumigatus and Aspergillus niger were isolated from lower respiratory samples. Antifungal therapy was administered to 9 patients (52.9%). Seven patients (77.8%) received voriconazole. The CAPA fatality case rate was 76.5%. The results of the study indicate the need to increase the awareness of medical staff about the possibility of fungal co-infections in ICU patients with COVID-19 and to use the available diagnostic and therapeutic tools more effectively.
More Related Videos
Related Concept Videos
01:30Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
01:30Pneumonia III: Complications and Assessment
01:21Acute Respiratory Failure-II
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
01:30Acute Respiratory Failure-III
01:25Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
01:21Acute Respiratory Failure-I
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...